Table 5.
Prostate cancer (men only) HR (95% CI)1 | Breast cancer (women only) HR (95% CI)1 | |||||
---|---|---|---|---|---|---|
Group | 1 year FU | 2–5 years FU | 6–10 years FU | 1 year FU | 2–5 years FU | 6–10 years FU |
Comparison2 | 1 | 1 | 1 | 1 | 1 | 1 |
Back | 5.42 (3.31, 8.88) | 1.12 (0.80, 1.56) | 1.43 (1.08, 1.90) | 2.36 (1.38, 4.01) | 1.12 (0.83, 1.51) | 1.03 (0.77, 1.39) |
Shoulder | 1.12 (0.34, 3.68) | 1.47 (0.96, 2.23) | 1.54 (1.06, 2.23) | 1.53 (0.60, 3.87) | 1.16 (0.75, 1.80) | 0.63 (0.37, 1.08) |
Neck | 3.46 (1.58, 7.58) | 1.50 (0.96, 2.34) | 1.67 (1.12, 2.46) | 1.28 (0.46, 3.60) | 0.81 (0.48, 1.37) | 1.02 (0.66, 1.58) |
Hip | 6.08 (2.87,12.85) | 1.45 (0.81, 2.61) | 1.15 (0.61, 2.18) | 2.76 (1.24, 6.16) | 1.88 (1.22, 2.89) | 0.62 (0.30, 1.25) |
Adjusted for age, BMI, smoking status, drinking status, deprivation and comorbidity.
No musculoskeletal consultation in the 2 years prebaseline. FU = follow-up. Bold indicates p<0.05.